Advertisement

Different routes of administering EW-7197 versus EW-7197⋅HBr for preventing peritoneal adhesion in a rat model

Published:December 26, 2022DOI:https://doi.org/10.1016/j.surg.2022.11.016

      Abstract

      Background

      The relatively low aqueous solubility of EW-7197 that was administered orally may have affected the desired concentration in the systemic circulation for treating peritoneal adhesion. This experimental study aimed to compare the efficacy of different routes of administering EW-7197 (2-fluoro-N-[(5-[6-methylpyridin-2-yl]-4-[(1,2,4)triazolo(1,5-a)pyridin-6-yl]-1H-imidazol-2-yl)methyl]aniline) and EW-7197·hydrobromide (HBr), with improved aqueous solubility, for inhibiting peritoneal adhesion in a rat model.

      Methods

      After peritoneal adhesion induction, 30 male Sprague-Dawley rats were randomly divided into 5 groups with 6 rats in each: group A, sham control; group B, orally administered 25 mg/kg of EW-7197·HBr for 7 days; group C, locally administered 25 mg/kg of EW-7197·HBr; group D, orally administered 20 mg/kg of EW-7197 for 7 days; and group E, locally administered 20 mg/kg of EW-7197. Gross examination, histologic staining (hematoxylin and eosin and Masson’s trichrome), and immunohistochemical analyses (Ki-67 and α-smooth muscle actin marker [α-SMA]) were performed to evaluate the efficacy of both drugs.

      Results

      All procedures were technically successful. All treatment groups, except for group C, showed significantly reduced incidence, quality, tenacity, fibrosis, and collagen deposition scores and lowered expressions of Ki-67– and α-SMA–positive cells compared with group A. When comparing between groups, all scores were significantly lower in group B than in group C (all P < .001), whereas no significant difference was noted in any of the scores between groups D and E and groups B and E (all P > .05).

      Conclusion

      Orally administering EW-7197·HBr and both orally and locally administering EW-7197 significantly prevented peritoneal adhesion formation, and orally administering EW-7197·HBr was the most effective overall.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Herrick S.E.
        • Wilm B.
        Post-surgical peritoneal scarring and key molecular mechanisms.
        Biomolecules. 2021; 11: 692
        • Stommel M.W.J.
        • Ten Broek R.P.G.
        • Strik C.
        • et al.
        Multicenter observational study of adhesion formation after open-and laparoscopic surgery for colorectal cancer.
        Ann Surg. 2018; 267: 743-748
        • Leclercq R.M.
        • Van Barneveld K.W.
        • Schreinemacher M.H.
        • et al.
        Postoperative abdominal adhesions and bowel obstruction: a survey among Dutch general practitioners.
        Eur J Gen Pract. 2015; 21: 176-182
        • Tang J.
        • Xiang Z.
        • Bernards M.T.
        • Chen S.
        Peritoneal adhesions: occurrence, prevention and experimental models.
        Acta Biomater. 2020; 116: 84-104
        • Demco L.
        Pain mapping of adhesions.
        J Am Assoc Gynecol Laparosc. 2004; 11: 181-183
        • Sulaiman H.
        • Gabella G.
        • Davis M.C.
        • et al.
        Presence and distribution of sensory nerve fibers in human peritoneal adhesions.
        Ann Surg. 2001; 234: 256-261
        • Strik C.
        • Stommel M.W.J.
        • Hol J.C.
        • van Goor H.
        • Ten Broek R.P.G.
        Quality of life, functional status and adhesiolysis during elective abdominal surgery.
        Am J Surg. 2018; 215: 104-112
        • Tabibian N.
        • Swehli E.
        • Boyd A.
        • Umbreen A.
        • Tabibian J.H.
        Abdominal adhesions: a practical review of an often overlooked entity.
        Ann Med Surg (Lond). 2017; 15: 9-13
        • Sakai S.
        • Ueda K.
        • Taya M.
        Peritoneal adhesion prevention by a biodegradable hyaluronic acid-based hydrogel formed in situ through a cascade enzyme reaction initiated by contact with body fluid on tissue surfaces.
        Acta Biomater. 2015; 24: 152-158
        • Jin C.H.
        • Krishnaiah M.
        • Sreenu D.
        • et al.
        Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2 -yl)methyl)-2-fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-beta type I receptor kinase as cancer immunotherapeutic/antifibrotic agent.
        J Med Chem. 2014; 57: 4213-4238
        • Tsauo J.
        • Song H.Y.
        • Choi E.Y.
        • et al.
        EW-7197, an oral transforming growth factor beta type I receptor kinase inhibitor, for preventing peritoneal adhesion formation in a rat model.
        Surgery. 2018; 164: 1100-1108
        • Savjani K.T.
        • Gajjar A.K.
        • Savjani J.K.
        Drug solubility: importance and enhancement techniques.
        ISRN Pharm. 2012; (2012): 195727
        • Anselmo A.C.
        • Gokarn Y.
        • Mitragotri S.
        Non-invasive delivery strategies for biologics.
        Nat Rev Drug Discov. 2019; 18: 19-40
        • Goldberg M.
        • Gomez-Orellana I.
        Challenges for the oral delivery of macromolecules.
        Nat Rev Drug Discov. 2003; 2: 289-295
        • Larhed A.W.
        • Artursson P.
        • Bjork E.
        The influence of intestinal mucus components on the diffusion of drugs.
        Pharm Res. 1998; 15: 66-71
        • Cone R.A.
        Barrier properties of mucus.
        Adv Drug Deliv Rev. 2009; 61: 75-85
        • Narendra S.C.
        • Chalise J.P.
        • Magnusson M.
        • Uppugunduri S.
        Local but not systemic administration of uridine prevents development of antigen-induced arthritis.
        PLoS One. 2015; 10e0141863
        • Jun E.J.
        • Park J.H.
        • Tsauo J.
        • et al.
        EW-7197, an activin-like kinase 5 inhibitor, suppresses granulation tissue after stent placement in rat esophagus.
        Gastrointest Endosc. 2017; 86: 219-228
        • Whang S.H.
        • Astudillo J.A.
        • Sporn E.
        • et al.
        In search of the best peritoneal adhesion model: comparison of different techniques in a rat model.
        J Surg Res. 2011; 167: 245-250
        • Huckle A.W.
        • Fairclough L.C.
        • Todd I.
        Prophylactic antibiotic use in COPD and the potential anti-inflammatory activities of antibiotics.
        Respir Care. 2018; 63: 609-619
        • Wallwiener M.
        • Brucker S.
        • Hierlemann H.
        • Brochhausen C.
        • Solomayer E.
        • Wallwiener C.
        Innovative barriers for peritoneal adhesion prevention: liquid or solid? A rat uterine horn model.
        Fertil Steril. 2006; 86: 1266-1276
        • Onishi A.
        • Akimoto T.
        • Morishita Y.
        • et al.
        Peritoneal fibrosis induced by intraperitoneal methylglyoxal injection: the role of concurrent renal dysfunction.
        Am J Nephrol. 2014; 40: 381-390
        • Son J.Y.
        • Park S.Y.
        • Kim S.J.
        • et al.
        EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis.
        Mol Cancer Ther. 2014; 13: 1704-1716
        • Hida A.I.
        • Bando K.
        • Sugita A.
        • et al.
        Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.
        J Clin Pathol. 2015; 68: 356-361
        • Liu Z.
        • Cheng S.
        • Gu C.
        • Pei H.
        • Hong X.
        Effect of hydrogen-rich saline on postoperative intra-abdominal adhesion bands formation in mice.
        Med Sci Monit. 2017; 23: 5363-5373
        • Harris E.S.
        • Morgan R.F.
        • Rodeheaver G.T.
        Analysis of the kinetics of peritoneal adhesion formation in the rat and evaluation of potential antiadhesive agents.
        Surgery. 1995; 117: 663-669
        • Skrdla P.J.
        Estimating the maximal solubility advantage of drug salts.
        Int J Pharm. 2021; 595: 120228